CADTH recommends that general public drug plans reimburse Hemgenix to the cure of hemophilia B if certain situations are fulfilled.a panel of three of clinical experts with skills in diagnosing and treating people with hemophilia B“We've been entirely committed to Doing the job together with payers as well as other stakeholders to obtain this,”